Penumbra (PEN) Interest Expenses (2014 - 2026)
Penumbra's (PEN) quarterly Interest Expenses came in at $5.9 million in Q1 2026, up 6.16% year-on-year from $5.6 million in Q1 2025, and down 17.06% on a QoQ basis from $7.1 million in Q4 2025.
Penumbra (PEN) Interest Expenses (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Interest Expenses data on file, last reported at $5.9 million in Q1 2026.
- On a quarterly basis, Interest Expenses rose 6.16% year-over-year to $5.9 million in Q1 2026; TTM through Mar 2026 was $13.7 million, a 13.45% increase from a year earlier, with the FY2025 full-year figure at $28.8 million, up 8.27% from the prior year.
- Interest Expenses for Q1 2026 stood at $5.9 million, down from $7.1 million in the prior quarter.
- Over the last five years, Interest Expenses for PEN reached as high as $266.5 million in Q1 2022 and fell as low as -$8.4 million in Q4 2023.
- Historically, Interest Expenses has averaged $48.0 million across 5 years, with a median of $4.7 million in 2023.
- On a YoY basis, Interest Expenses climbed as much as 7941.25% in 2022 and fell as far as 928.83% in 2022.
- Year by year, Interest Expenses stood at -$6.3 million in 2022, then tumbled by 32.74% to -$8.4 million in 2023, then jumped by 169.4% to $5.8 million in 2024, then rose by 22.39% to $7.1 million in 2025, then retreated by 17.06% to $5.9 million in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $5.9 million in Q1 2026, $7.1 million in Q4 2025, and $338000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.50 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 142.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 512.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 400.20 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 3.10 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 96.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | -140.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -97.17 Mn |
| 10 | Penumbra | 12.55 Bn | 11.94 Bn | 253.41 Mn | 5.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.91 Mn |
| Mar 31, 2026 | 5.91 Mn |
| Dec 31, 2025 | 7.12 Mn |
| Dec 31, 2025 | 7.12 Mn |
| Sep 30, 2025 | 338,000.00 |
| Sep 30, 2025 | 338,000.00 |
| Jun 30, 2025 | 319,000.00 |
| Jun 30, 2025 | 319,000.00 |
| Mar 31, 2025 | 5.56 Mn |
| Mar 31, 2025 | 5.56 Mn |
| Dec 31, 2024 | 5.82 Mn |
| Dec 31, 2024 | 5.82 Mn |
| Sep 30, 2024 | 336,000.00 |
| Sep 30, 2024 | 336,000.00 |
| Jun 30, 2024 | 344,000.00 |
| Jun 30, 2024 | 344,000.00 |
| Mar 31, 2024 | 5.34 Mn |
| Mar 31, 2024 | 5.34 Mn |
| Dec 31, 2023 | -8.39 Mn |
| Dec 31, 2023 | -8.39 Mn |